Trials / Completed
CompletedNCT05413889
Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model
Validation and Implementation Design of a Pragmatic Randomized Controlled Trial Leveraging Epic Systems 30-day Unplanned Readmission Risk Model
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to assess the implementation of a computerized clinical decision support (cCDS) tool for identifying patients at high risk of unplanned readmission who could benefit from existing care programs aimed at reducing readmissions
Detailed description
Providers from either service, which includes attending physicians, residents, hospitalists, and advanced practice providers (APPs), will be randomly allocated to an intervention group (IG) or control group (CG). The IG will consist of placing the Epic 30-day unplanned readmission risk score in the story board of providers. If a patient is identified as having a high risk of readmission defined as readmission risk \>20%, a link to transitional and supportive care services (TSC) will be appear in the story board. Providers will determine which TSC is best for the patient and may order whichever TSC is appropriate for the patient. The study team will not recommend TSCs. The risk of readmission score will be present from the time of admission for those in the IG. The CG will have the same TSC orders available to them; however, they will not have the risk of readmission score present in their workflow, as such the embedded link to TSC will also not be present.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Epic 30-day unplanned readmission risk score | If a patient is identified as having a high risk of readmission defined as readmission risk \>20%, a link to transitional and supportive care services (TSC) will be appear in the story board. |
Timeline
- Start date
- 2023-02-02
- Primary completion
- 2023-08-15
- Completion
- 2023-08-17
- First posted
- 2022-06-10
- Last updated
- 2023-12-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05413889. Inclusion in this directory is not an endorsement.